UBS Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

UBS Group’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-747,600	Closed	-$5.36M	–	10234
2024 Q3	$5.36M	Buy	747,600 +299,800	+67%	+$2.13M	﹤0.01%	3000
2024 Q2	$3.28M	Buy	+447,800	New	+$3.91M	﹤0.01%	3260
2024 Q1	–	Sell	-314,200	Closed	-$2.2M	–	9778
2023 Q4	$2.2M	Buy	+314,200	New	+$2.09M	﹤0.01%	3719
2023 Q1	–	Sell	-382,500	Closed	-$2.67M	–	10072
2022 Q4	$2.67M	Buy	+382,500	New	+$3.93M	﹤0.01%	3095
2022 Q2	–	Sell	-93,600	Closed	-$1.95M	–	10691
2022 Q1	$1.95M	Buy	+93,600	New	+$2.04M	﹤0.01%	3450

Other funds holding MSOS

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

IECM

Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

UBS Group's MSOS Position: Q1 2026 in Review

UBS Group reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 74% in Q1 2026, selling an estimated $829K and leaving 69,620 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #6516.

UBS Group first reported a position in MSOS in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.85M in Q1 2024. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

UBS Group held 69,620 shares of AdvisorShares Pure US Cannabis ETF worth $247K as of Q1 2026.
UBS Group sold 202,310 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $829K.
AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6516 holding.
UBS Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and has held it in 17 quarters since.
UBS Group's AdvisorShares Pure US Cannabis ETF position peaked at $2.85M in Q1 2024.
168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.